These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12944505)

  • 1. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.
    Franklin A; Parmentier-Batteur S; Walter L; Greenberg DA; Stella N
    J Neurosci; 2003 Aug; 23(21):7767-75. PubMed ID: 12944505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
    Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpsychotropic cannabinoid receptors regulate microglial cell migration.
    Walter L; Franklin A; Witting A; Wade C; Xie Y; Kunos G; Mackie K; Stella N
    J Neurosci; 2003 Feb; 23(4):1398-405. PubMed ID: 12598628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.
    Farquhar-Smith WP; Jaggar SI; Rice AS
    Pain; 2002 May; 97(1-2):11-21. PubMed ID: 12031775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabimimetic fatty acid derivatives in cancer and inflammation.
    Di Marzo V; Melck D; De Petrocellis L; Bisogno T
    Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):43-61. PubMed ID: 10785541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
    De Petrocellis L; Bisogno T; Ligresti A; Bifulco M; Melck D; Di Marzo V
    Fundam Clin Pharmacol; 2002 Aug; 16(4):297-302. PubMed ID: 12570018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
    Jacobsson SO; Fowler CJ
    Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?
    Fowler CJ; Jacobsson SO
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):193-200. PubMed ID: 12052035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.
    Vázquez C; Tolón RM; Pazos MR; Moreno M; Koester EC; Cravatt BF; Hillard CJ; Romero J
    Neurobiol Dis; 2015 Jul; 79():41-50. PubMed ID: 25917763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.
    Skaper SD; Buriani A; Dal Toso R; Petrelli L; Romanello S; Facci L; Leon A
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3984-9. PubMed ID: 8633002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
    Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids control spasticity in a multiple sclerosis model.
    Baker D; Pryce G; Croxford JL; Brown P; Pertwee RG; Makriyannis A; Khanolkar A; Layward L; Fezza F; Bisogno T; Di Marzo V
    FASEB J; 2001 Feb; 15(2):300-2. PubMed ID: 11156943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.
    Sugiura T; Kondo S; Kishimoto S; Miyashita T; Nakane S; Kodaka T; Suhara Y; Takayama H; Waku K
    J Biol Chem; 2000 Jan; 275(1):605-12. PubMed ID: 10617657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
    Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.
    Hillard CJ
    Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):3-18. PubMed ID: 10785538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.
    Amorós I; Barana A; Caballero R; Gómez R; Osuna L; Lillo MP; Tamargo J; Delpón E
    J Mol Cell Cardiol; 2010 Jan; 48(1):201-10. PubMed ID: 19616555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?
    Lambert DM; Di Marzo V
    Curr Med Chem; 1999 Aug; 6(8):757-73. PubMed ID: 10469890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
    McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
    BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
    Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
    Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of pain initiation by endogenous cannabinoids.
    Calignano A; La Rana G; Giuffrida A; Piomelli D
    Nature; 1998 Jul; 394(6690):277-81. PubMed ID: 9685157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.